Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Clinical relevance of breast and gastric cancer-associated polymorphisms as potential susceptibility markers for oral clefts in the Brazilian population

  • Renato Assis Machado1Email author,
  • Edimilson Martins de Freitas2,
  • Sibele Nascimento de Aquino3,
  • Daniella Reis B. Martelli2,
  • Mário Sérgio Oliveira Swerts4,
  • Silvia Regina de Almeida Reis5,
  • Darlene Camati Persuhn6,
  • Helenara Salvati Bertolossi Moreira7,
  • Verônica Oliveira Dias2,
  • Ricardo D. Coletta1 and
  • Hercílio Martelli-Júnior2, 4
BMC Medical GeneticsBMC series – open, inclusive and trusted201718:39

https://doi.org/10.1186/s12881-017-0390-y

Received: 4 August 2016

Accepted: 3 March 2017

Published: 4 April 2017

Abstract

Background

Epidemiological studies have indicated a higher incidence of breast and gastric cancer in patients with nonsyndromic cleft lip with or without cleft palate (NSCL ± P) and their relatives, which can be based on similar genetic triggers segregated within family with NSCL ± P.

Methods

This multicenter study evaluated the association of 9 single nucleotide polymorphisms (SNP) in AXIN2 and CDH1, representing genes consistently altered in breast and gastric tumors, with NSCL ± P in 223 trios (father, mother and patient with NSCL ± P) by transmission disequilibrium test (TDT).

Results

Our results showed that the minor A allele of rs7210356 (p = 0.01) and the T-G-G-A-G haplotype formed by rs7591, rs7210356, rs4791171, rs11079571 and rs3923087 SNPs (p = 0.03) in AXIN2 were significantly under-transmitted to patients with NSCL ± P. In CDH1 gene, the C-G-A-A and A-G-A-G haplotypes composed by rs16260, rs9929218, rs7186053 and rs4783573 polymorphisms were respectively over-transmitted (p = 0.01) and under-transmitted (p = 0.008) from parents to the children with NSCL ± P.

Conclusions

The results suggest that polymorphic variants in AXIN2 and CDH1 may be associated with NSCL ± P susceptibility, and reinforce the putative link between cancer and oral clefts.

Keywords

Nonsyndromic cleft lip with or without cleft palate Breast cancer Gastric cancer AXIN2 CDH1

Background

Oral clefts are the most common congenital craniofacial abnormalities in humans [1, 2]. About 70% of cases occur as a nonsyndromic form, and the remaining 30% are associated with Mendelian disorders or chromosomal, teratogenic and sporadic conditions [3, 4]. Nonsyndromic oral clefts are traditionally divided in cleft lip only (NSCLO), cleft lip and palate (NSCLP) and cleft palate only (NSCPO), however, as there are similarities in both epidemiologic features and embryologic timing for both NSCLO and NSCLP, they are considered variants of the same defect and grouped together to form the group cleft lip with or without cleft palate (NSCL ± P) [5, 6]. Oral clefts affect approximately 1 in 500–2000 live births, with variable prevalence around the world, often attributed to ethnic and environmental differences. American and Asian populations have a high prevalence (1:500), populations from Europe have intermediate prevalence (1:1000) and the lowest prevalence is observed in Africans and their descendants (1:2500) [7]. Previous studies have revealed that NSCL ± P etiology is dependent of interactions between environmental and genetic risk factors [8, 9]. In fact, epidemiological studies and analysis of animal models have provided evidences of a putative participation of agrotoxics, cigarette smoking, consumption of alcohol and drugs, malnutrition and some viral infections in etiology of NSCL ± P [10, 11]. Genetic linkage and genome-wide association studies (GWAS) have described several genes and loci in association with NSCL ± P, including IRF6, VAX1, MSX1, FOXE1, MYH9, MAFB, ABCA4, BMP4, FGFR2, TGFA, TGFB3, MTHFR, GSTT1, PDGFC, FGF8, PVRL1, SUMO1, CRISPLD2 and the regions 8q24 and 17q22 [1, 12, 13].

Epidemiological studies have shown a high risk of oral clefts in families with cancer, while others have provided consistent data about increased risk of cancer in patients with oral cleft and their relatives [1418]. This association has been explicated because specific cancers, including those of breast and stomach, and NSCL ± P may share similar genetic etiology [14, 1921]. The Wingless/integrase-1 (WNT) signaling pathway is an evolutionarily conserved pathway with major roles in cell migration, cell polarity, cell fate determination and organogenesis during embryonic development, including orofacial morphogenesis [2224], and aberrant expression of several WNT family members is common in cancers [25, 26]. The canonical WNT signaling is mediated by the translocation of β-catenin to the nucleus, where it activates transcription of several factors regulating proliferation and differentiation, while noncanonical WNT signaling is β-catenin independent [27].

The axis inhibition protein 2 (AXIN2), a member of the WNT pathway, is associated with the development and progression of breast cancers [21, 28], and polymorphisms in AXIN2 are associated with increased risk for breast cancer in premenopausal women [29]. E-cadherin, encoded by the CDH1 (cadherin-1) gene, is a transmembrane glycoprotein playing a crucial role in maintaining cell-to-cell adhesion [30]. E-cadherin has been reported to be a tumor suppressor and to be downregulated in gastric cancer [3133]. Germline CDH1 mutations confer an increased risk of developing both gastric and breast cancer [34]. Genetics studies revealed that polymorphic variants in AXIN2 and CDH1 are risk factors for NSCL ± P and tooth agenesis [3540]. In this study, we postulated that single nucleotide polymorphisms (SNP) in genes associated with breast and gastric pathogenesis (AXIN2 and CDH1) might be related to the risk of NSCL ± P. Thus, we evaluated the association of 9 SNPs in CDH1 and AXIN2 with the risk of NSCL ± P using a family-based study design (case-parent trios). This design has the advantage of bypass problems with population stratification. Indeed, the main disadvantage of case-control studies, the most common approach in genetic studies, is unaccounted population admixture with a possible threat to the validity of the obtained results.

Methods

This study included samples from four Brazilian states: Minas Gerais state (Center for Rehabilitation of Craniofacial Anomalies, Dental School, University of José Rosário Vellano, Alfenas-MG), located in the Southeastern region of Brazil, Paraná state (Association of Carrier of Lip and Palate Cleft-APOFILAB, Cascavel-PR), in the Southern region, Paraíba state (University Hospital of Lauro Wanderley-HULW, João Pessoa-PB) and Bahia state (Santo Antonio Hospital, Salvador-BA), which are located in the Northeast region. The cohort was composed of 223 trios composed of one affected offspring and two healthy parents. Information on demographic characteristics, including gender and race, and family history of oral cleft and cancer were collected through direct interview of the patients and/or mothers (Additional file 1: Table S1). All patients were diagnosed independently and screened for the presence of associated anomalies or syndromes by the team of specialists from each center, and only patients with the nonsyndromic form were included. The NSCL ± P was classified with the incisive foramen as reference [41].

The genomic DNA was isolated from buccal mucosa cells obtained by mouthwash with a 3% sucrose solution, using a salting-out protocol previously described [42]. SNPs, including rs16260, rs9929218, rs7186053 and rs4783573 in CDH1 and rs7591, rs7210356, rs4791171, rs11079571 and rs3923087 in AXIN2 (Table 1), were genotyped using the Taqman genotyping assay (assay-on-demand, Applied Biosystems). Genotyping analyses were randomly repeated in 10% of the samples, and the concordance rate was 100%. These SNPs were selected based on their minor allele frequencies (www.ncbi.nlm.nih.gov) and because they were described as risk factors for oral cleft and breast and gastric cancer [29, 37, 39, 40, 4346]. The study was approved by the ethics review board of each of the centers or hospitals affiliated with the collaborative study. Written informed consent was obtained from the parents or guardians and/or the participants.
Table 1

Characteristics of the single-nucleotide polymorphisms (SNPs)

SNP

Gene

Chromosome

Location

Position

Alleles

rs16260

CDH1

16

promoter

68,737,131

C/A

rs9929218

CDH1

16

intron

68,787,043

G/A

rs7186053

CDH1

16

intron

68,805,390

G/A

rs4783573

CDH1

16

intron

68,806,685

G/A

rs7591

AXIN2

17

3’ UTR

65,528,964

A/T

rs7210356

AXIN2

17

intron

65,532,832

G/A

rs4791171

AXIN2

17

intron

65,545,379

A/G

rs11079571

AXIN2

17

intron

65,552,563

G/A

rs3923087

AXIN2

17

intron

65,553,143

A/G

Risk alleles in bold

For allele transmission analysis, the transmission disequilibrium test (TDT) was performed with the aid of the FBAT (Family Based Association Test) software. The haplotype-based analysis was conducted using the HBAT (Haplotype-Based Association Test) command in FBAT software. These tests are intended to verify the genotype-phenotype association from the unbalanced transmission of the alleles and haplotypes from healthy parents to affected children. The Z-score value measures the deviation from the null hypothesis, and positive Z-score indicates that the allele is over-transmitted to the affected offspring (is a risk factor), whereas a negative Z-score indicates under-transmission to affected offspring (is a protective factor). The pair-wise linkage disequilibrium (LD) was estimated from the combined data of all trios calculating D’ and r2 using the using Haploview software (v4.2). The p value of <0.05 was considered statistically significant.

Results

Our results showed that the minor A allele of AXIN2 rs7210356 was significantly under-transmitted to patients with NSCL ± P (p = 0.01) (Table 2). HBAT analyses showed the C-G-A-A and A-G-A-G haplotypes formed by rs16260, rs9929218, rs7186053 and rs4783573 in CDH1 were significantly transmitted from parents to the children with NSCL ± P (p = 0.01 and p = 0.008, respectively) (Table 3). In AXIN2 gene, the frequency of the T-G-G-A-G haplotype formed by rs7591, rs7210356, rs4791171, rs11079571 and rs3923087 SNPs was also under-transmitted to patients with NSCL ± P (p = 0.03) (Table 4).
Table 2

Transmission disequilibrium test (TDT) of the single-nucleotide polymorphisms (SNPs) in nonsyndromic cleft lip with or without cleft palate (NSCL ± P) trios

SNP

MAF

Number of families

T/NT

Z score

p value

rs16260

0.295

135

86/49

1.00

0.31

rs9929218

0.271

133

78/55

-0.46

0.64

rs7186053

0.329

134

84/50

-0.98

0.32

rs4783573

0.523

146

103/43

-1.39

0.16

rs7591

0.543

154

121/33

0.55

0.58

rs7210356

0.081

54

34/20

-2.47

0.01

rs4791171

0.616

139

118/21

0.36

0.71

rs11079571

0.215

99

50/49

-1.68

0.09

rs3923087

0.606

136

116/20

0.00

1.00

MAF: minor allele frequency, T/NT: transmission/non-transmission counts

Table 3

Haplotype family-based association test for CDH1 rs16260, rs9929218, rs7186053 and rs4783573 performed using HBAT

Haplotype*

Number of families

Frequency

Z score

p value

C-G-G-G

119

0.336

0.73

0.46

C-G-G-A

94

0.216

0.80

0.42

A-A-A-A

82

0.185

-0.71

0.47

C-G-A-A

42

0.064

-2.48

0.01

A-G-A-G

22

0.032

2.66

0.008

C-A-G-G

17

0.031

-0.07

0.94

C-G-A-G

21

0.029

-1.20

0.23

A-A-G-A

20

0.025

0.64

0.52

C-A-G-A

16

0.018

-0.96

0.34

A-A-G-G

12

0.015

-0.14

0.88

A-G-G-G

10

0.013

-0.31

0.76

A-A-A-G

12

0.010

1.12

0.26

*Sequence: rs16260, rs9929218, rs7186053 and rs4783573

Table 4

Haplotype family-based association test for AXIN2 rs7591, rs7210356, rs4791171, rs11079571 and rs3923087 performed using HBAT

Haplotype*

Number of families

Frequency

Z score

p value

T-G-G-G-G

96

0.486

1.45

0.15

A-G-A-G-A

77

0.158

0.75

0.45

A-G-A-A-A

62

0.121

0.02

0.98

A-G-G-G-G

30

0.052

0.35

0.73

A-A-A-A-A

17

0.031

-1.89

0.06

T-G-G-G-G

20

0.030

0.15

0.88

A-A-A-G-G

15

0.029

-0.37

0.71

A-G-A-G-G

14

0.019

-1.39

0.16

T-G-G-A-G

12

0.016

-2.08

0.03

A-G-G-A-G

11

0.013

0.39

0.69

*Sequence: rs7591, rs7210356, rs4791171, rs11079571 and rs3923087

The LD pattern of the SNPs examined is displayed in Table 5. The LD values between CDH1 SNPs were low, whereas AXIN2 SNPs rs7591, rs7210256 and rs4791171 were in complete linkage disequilibrium (rs7591 and rs7210356: D’ = 0.97 and r 2 = 0.10, rs7591 and rs4791171: D’ = 0.93 and r 2 = 0.68, rs7210356 and rs4791171: D’ = 0.95 and r 2 = 0.12).
Table 5

Linkage disequilibrium analysis of the CDH1 (A) and AXIN2 (B) SNP. D’ coefficient is above the diagonal and r’ is below diagonal

A

 

rs16260

rs9929218

rs7186053

rs4783573

 

 rs16260

-

0.77

0.69

0.49

 

 rs9929218

0.55

-

0.57

0.59

 

 rs7186053

0.41

0.26

-

0.48

 

 rs4783573

0.09

0.12

0.10

-

 

B

 

rs7591

rs7210356

rs4791171

rs11079571

rs3923087

 rs7591

-

0.97

0.93

0.78

0.77

 rs7210356

0.10

-

0.95

0.35

0.27

 rs4791171

0.68

0.12

-

0.74

0.79

 rs11079571

0.20

0.04

0.23

-

0.86

 rs3923087

0.47

0.01

0.61

0.31

-

Discussion

Although the exact environmental and genetic risk factors associated with NSCL ± P remains unclear, the understanding of the genetic mechanisms involved in this malformation are evolving. Interestingly, recent studies have demonstrated a relationship between congenital malformations and malignancies, and genetic alterations in AXIN2 and CDH1 are associated with both NSCL ± P [37, 39, 47] and cancer of breast and gastric [21, 28, 29, 3134]. In this study we explored the clinical relevance of breast and gastric cancer-associated polymorphisms in AXIN2 and CDH1 with NSCL ± P risk in the Brazilian population. Our results suggest that the AXIN2 rs7210356 SNP is associated with the occurrence of NSCL ± P in the investigated population. This SNP was associated with breast cancer risk in premenopausal but not in postmenopausal women [29]. The impact of the rs7210356 polymorphism in lip and palate development is unclear and our findings are of interest especially to understand this association. Haplotype analysis showed that five SNPs in AXIN2 (rs7591, rs7210356, rs4791171, rs11079571 and rs3923087) were associated with occurrence of NSCL ± P. Previously studies revealed that the both rs7591 and rs3923087 were associated with NSCL ± P and tooth agenesis [37, 46].

CDH1 haplotypes composed by rs16260, rs9929218, rs7186053 and rs4783573 were associated with NSCL ± P in our study population. Many reports showed that rs16260 is associated with the development of gastric cancer [45, 48], but it is controversial its association with craniofacial development [39, 40]. Similarly, rs9929218 was shown to have a borderline association with unilateral NSCL/P in Brazilian population [37] as well as the haplotype composed of rs9929218, rs7186053, rs4783573 and rs16958383 to NSCL/P in the population of Warsaw [40]. CDH1 plays a key role in cell adhesion, which is vital to normal development, including craniofacial morphogenesis and palatal fusion [49]. Thus, further examination of haplotypes in CDH1 gene, including rs16260, rs9929218, rs7186053 and rs4783573, is needed to identify the molecular relevant causes.

Conclusions

In summary, little is known about the relationship between AXIN2 and CDH1 genes and oral clefts in humans. In the present study identified one SNP and one haplotype in AXIN2 gene and two haplotypes in CDH1 gene significantly associated with NSCL ± P susceptibility in Brazilian population. Except the C-G-A-A haplotype formed by rs16260, rs9929218, rs7186053 and rs4783573 in CDH1 gene which was associated with increased risk of NSCL ± P, the others haplotypes in AXIN2 and CDH1 genes, as well as the rs7210356 allele alone, were associated in a protective manner to NSCL ± P. Though, the population size in our study is small and the significant results need to be confirmed in larger groups with known family history of breast and gastric cancer to better understand the interactions between AXIN2 and CDH1 genes in the development of NSCL ± P.

Abbreviations

AXIN2: 

Axis inhibition protein 2

CDH1: 

Cadherin-1

FBAT: 

Family based association test

HBAT: 

Haplotype-based association test

MAF: 

Minor allele frequency

NSCL ± P: 

Nonsyndromic cleft lip with or without cleft palate

NSCLO: 

Nonsyndromic cleft lip only

NSCLP: 

Nonsyndromic cleft lip and palate

NSCPO: 

Nonsyndromic cleft palate only

OR: 

Odds ratio

SNP: 

Single nucleotide polymorphism

T/NT: 

Transmission/non-transmission counts

TDT: 

Transmission disequilibrium test

Declarations

Acknowledgments

The authors thank all the study subjects and research staff who participated in this work.

Funding

This work was supported by grants from Research Support Foundation of Minas Gerais – FAPEMIG, National Council for Scientific and Technological Development – CNPq, Coordination of Improvement of High Education Personnel (CAPES) and Procad/Casadinho.

Availability of data and materials

All data and materials supporting the conclusions of this article are included within the article and its Additional file 1: Table S1.

Authors’ contributions

RC and HMJ designed and supervised the study. RAM, SNA, DRM, MSO, SRR, DCP, HSM and VOD recruited participants, analyzed and interpreted the data, drafted and revised the manuscript; RAM and EMF performed laboratory experiments, analyzed and interpreted the data, assisted with drafting the manuscript. All authors have read and approved the final version of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Participants were recruited from the Center for Rehabilitation of Craniofacial Anomalies (located in the Southeastern region of Brazil), Association of Carrier of Lip and Palate Cleft-APOFILAB (located in the South of Brazil), University Hospital of Lauro Wanderley-HULW and Santo Antonio Hospital, which are located in the Northeastern region. This study was approved by the institutional review board of each participating hospitals. Written consents were obtained from each participant.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Oral Diagnosis, Dental School, State University of Campinas
(2)
Stomatology Clinic, Dental School, State University of Montes Claros
(3)
School of Dentistry, Federal University of Juiz de Fora
(4)
Center for Rehabilitation of Craniofacial Anomalies, University of José Rosário Vellano
(5)
Department of Basic Science, Bahiana School of Medicine and Public Health
(6)
Molecular Biology Departament, Federal University of Paraíba
(7)
Department of Physiotherapy, State University of Western Paraná

References

  1. Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12(3):167–78.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Marazita ML, Lidral AC, Murray JC, Field LL, Maher BS, Goldstein McHenry T, Cooper ME, Govil M, Daack-Hirsch S, Riley B, Jugessur A, Felix T, Morene L, Mansilla MA, Vieira AR, Doheny K, Pugh E, Valencia-Ramirez C, Arcos-Burgos M. Genome scan, fine-mapping, and candidate gene analysis of non-syndromic cleft lip with or without cleft palate reveals phenotype-specific differences in linkage and association results. Hum Hered. 2009;68(3):151–70.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Meng L, Bian Z, Torensma R, Von den Hoff JW. Biological mechanisms in palatogenesis and cleft palate. J Dent Res. 2009;88(1):22–33.View ArticlePubMedGoogle Scholar
  4. Mangold E, Ludwig KU, Nothen MM. Breakthroughs in the genetics of orofacial clefting. Trends Mol Med. 2011;17(12):725–33.View ArticlePubMedGoogle Scholar
  5. Harville EW, Wilcox AJ, Lie RT, Vindenes H, Abyholm F. Cleft lip and palate versus cleft lip only: are they distinct defects? Am J Epidemiol. 2005;162(5):448–53.View ArticlePubMedGoogle Scholar
  6. Grosen D, Chevrier C, Skytthe A, Bille C, Molsted K, Sivertsen A, Murray JC, Christensen K. A cohort study of recurrence patterns among more than 54,000 relatives of oral cleft cases in Denmark: support for the multifactorial threshold model of inheritance. J Med Genet. 2010;47(3):162–8.View ArticlePubMedGoogle Scholar
  7. Murthy J, Bhaskar L. Current concepts in genetics of nonsyndromic clefts. Indian J Plast Surg. 2009;42(1):68–81.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Machado RA, Moreira HS, de Aquino SN, Martelli-Junior H, de Almeida Reis SR, Persuhn DC, Wu T, Yuan Y, Coletta RD. Interactions between RAD51 rs1801321 and maternal cigarette smoking as risk factor for nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A. 2016;170(2):536–9.View ArticleGoogle Scholar
  9. Wu T, Schwender H, Ruczinski I, Murray JC, Marazita ML, Munger RG, Hetmanski JB, Parker MM, Wang P, Murray T, Taub M, Li S, Redett RJ, Fallin MD, Liang KY, Wu-Chou YH, Chong SS, Yeow V, Ye X, Wang H, Huang S, Jabs EW, Shi B, Wilcox AJ, Jee SH, Scott AF, Beaty TH. Evidence of gene-environment interaction for two genes on chromosome 4 and environmental tobacco smoke in controlling the risk of nonsyndromic cleft palate. PLoS One. 2014;9(2):e88088.View ArticlePubMedPubMed CentralGoogle Scholar
  10. James A, Oluwatosin B, Njideka G, Babafemi BOG, Olufemi D, Leo R, Folorunso I, Phylis OO. Cleft palate in hiv-exposed newborns of mothers on highly active antiretroviral therapy. Oral Surg. 2014;7 Suppl 1:102–6.PubMedPubMed CentralGoogle Scholar
  11. Figueiredo JC, Ly S, Magee KS, Ihenacho U, Baurley JW, Sanchez-Lara PA, Brindopke F, Nguyen TH, Nguyen V, Tangco MI, Giron M, Abrahams T, Jang G, Vu A, Zolfaghari E, Yao CA, Foong A, DeClerk YA, Samet JM, Magee W. Parental risk factors for oral clefts among Central Africans, Southeast Asians, and Central Americans. Birth Defects Res A Clin Mol Teratol. 2015;103(10):863–79.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Yuan Q, Blanton SH, Hecht JT. Genetic causes of nonsyndromic cleft lip with or without cleft palate. Adv Otorhinolaryngol. 2011;70:107–13.PubMedGoogle Scholar
  13. Mehrotra D. Genomic expression in non syndromic cleft lip and palate patients: a review. J Oral Biol Craniofac Res. 2015;5(2):86–91.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Taioli E, Ragin C, Robertson L, Linkov F, Thurman NE, Vieira AR. Cleft lip and palate in family members of cancer survivors. Cancer Invest. 2010;28(9):958–62.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Jindal A, Vieira AR. Family history of cleft lip and palate in subjects diagnosed with leukemia. Am J Med Genet A. 2012;158A(3):678–9.View ArticlePubMedGoogle Scholar
  16. Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, Olsen J. Do parents of children with congenital malformations have a higher cancer risk? a nationwide study in Denmark. Br J Cancer. 2002;87(5):524–8.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Vieira AR, Khaliq S, Lace B. Risk of cancer in relatives of children born with isolated cleft lip and palate. Am J Med Genet A. 2012;158A(6):1503–4.View ArticlePubMedGoogle Scholar
  18. Goncalves E, Martelli DR, Coletta RD, Vieira AR, Caldeira AP, Martelli Jr H. Risk of leukemia in first degree relatives of patients with nonsyndromic cleft lip and palate. Braz Oral Res. 2014;28(1):1–3.View ArticlePubMedGoogle Scholar
  19. Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C, Vekemans M, Hartmann A, Baert-Desurmont S, Alexandre C, Lejeune Dumoulin S, Marroni C, Martin C, Castedo S, Lovett M, Winston J, Machado JC, Attié T, Jabs EW, Cai J, Pellerin P, Triboulet JP, Scotte M, Le Pessot F, Hedouin A, Carneiro F, Blayau M, Seruca R. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet. 2006;43(2):138–42.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189–97.View ArticlePubMedGoogle Scholar
  21. Li S, Wang C, Liu X, Hua S. The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer. 2015;14(2):325–31.View ArticlePubMedGoogle Scholar
  22. Mani P, Jarrell A, Myers J, Atit R. Visualizing canonical Wnt signaling during mouse craniofacial development. Dev Dyn. 2010;239(1):354–63.PubMedPubMed CentralGoogle Scholar
  23. Chiquet BT, Blanton SH, Burt A, Ma D, Stal S, Mulliken JB, Hecht JT. Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet. 2008;17(14):2212–8.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Lu YP, Han WT, Liu Q, Li JX, Li ZJ, Jiang M, Xu W. Variations in WNT3 gene are associated with incidence of non-syndromic cleft lip with or without cleft palate in a northeast Chinese population. Genet Mol Res. 2015;14(4):12646–53.View ArticlePubMedGoogle Scholar
  25. Galamb O, Kalmár A, Péterfia B, Csabai I, Bodor A, Ribli D, Krenács T, Patai ÁV, Wichmann B, Barták BK, Tóth K, Valcz G, Spisák S, Tulassay Z, Molnár B. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics. 2016;11(8):588–602.View ArticlePubMedGoogle Scholar
  26. Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget. 2012;3(12):1546–56.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Baarsma HA, Konigshoff M, Gosens R. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Pharmacol Ther. 2013;138(1):66–83.View ArticlePubMedGoogle Scholar
  28. Wang SH, Li N, Wei Y, Li QR, Yu ZP. beta-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells. Mol Med Rep. 2014;9(3):973–8.PubMedGoogle Scholar
  29. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, Rider DN, Vachon CM, Cerhan JR, Olson JE, Couch FJ. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2101–8.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826(2):297–311.PubMedGoogle Scholar
  31. Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308.PubMedPubMed CentralGoogle Scholar
  32. Jiang B, Zhu K, Shao H, Bao C, Ou J, Sun W. Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis. Sci Rep. 2015;5:7891.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Li YL, Tian Z, Zhang JB, Fu BY. CDH1 promoter polymorphism and stomach cancer susceptibility. Mol Biol Rep. 2012;39(2):1283–6.View ArticlePubMedGoogle Scholar
  34. van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O’Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52(6):361–74.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Han Y, Zhou L, Ma L, Li D, Xu M, Yuan H, Ma J, Zhang W, Jiang H, Wu Y, Wang L, Pan Y. The axis inhibition protein 2 polymorphisms and non-syndromic orofacial clefts susceptibility in a Chinese Han population. J Oral Pathol Med. 2014;43(7):554–60.View ArticlePubMedGoogle Scholar
  36. Letra A, Bjork B, Cooper ME, Szabo-Rogers H, Deleyiannis FW, Field LL, Czeizel AE, Ma L, Garlet GP, Poletta FA, Mereb JC, Lopez-Camelo JS, Castilla EE, Orioli IM, Wendell S, Blanton SH, Liu K, Hecht JT, Marazita ML, Vieira AR, Silva RM. Association of AXIN2 with non-syndromic oral clefts in multiple populations. J Dent Res. 2012;91(5):473–8.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Letra A, Menezes R, Granjeiro JM, Vieira AR. AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts. Birth Defects Res A Clin Mol Teratol. 2009;85(2):169–73.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Bureau A, Parker MM, Ruczinski I, Taub MA, Marazita ML, Murray JC, Mangold E, Noethen MM, Ludwig KU, Hetmanski JB, Bailey-Wilson JE, Cropp CD, Li Q, Szymczak S, Albacha-Hejazi H, Alqosayer K, Field LL, Wu-Chou YH, Doheny KF, Ling H, Scott AF, Beaty TH. Whole exome sequencing of distant relatives in multiplex families implicates rare variants in candidate genes for oral clefts. Genetics. 2014;197(3):1039–44.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Song Y, Zhang S. Association of CDH1 promoter polymorphism and the risk of non-syndromic orofacial clefts in a Chinese Han population. Arch Oral Biol. 2011;56(1):68–72.View ArticlePubMedGoogle Scholar
  40. Hozyasz KK, Mostowska A, Wojcicki P, Lasota A, Offert B, Balcerek A, Dunin-Wilczyńska I, Jagodziński PP. Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate. Fam Cancer. 2014;13(3):415–21.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Spina V, Psillakis JM, Lapa FS, Ferreira MC. Classification of cleft lip and cleft palate. Suggested changes. Rev Hosp Clin Fac Med Sao Paulo. 1972;27(1):5–6.PubMedGoogle Scholar
  42. Aidar M, Line SR. A simple and cost-effective protocol for DNA isolation from buccal epithelial cells. Braz Dent J. 2007;18(2):148–52.View ArticlePubMedGoogle Scholar
  43. Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients. PLoS One. 2013;8(3):e59555.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Jing H, Dai F, Zhao C, Yang J, Li L, Kota P, Mao L, Xiang K, Zheng C, Yang J. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis. Medicine (Baltimore). 2014;93(19):e107.View ArticleGoogle Scholar
  45. Zhan Z, Wu J, Zhang JF, Yang YP, Tong S, Zhang CB, Li J, Yang XW, Dong W. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep. 2012;39(8):8107–13.View ArticlePubMedGoogle Scholar
  46. Mostowska A, Hozyasz KK, Wojcicki P, Lasota A, Dunin-Wilczynska I, Jagodzinski PP. Association of DVL2 and AXIN2 gene polymorphisms with cleft lip with or without cleft palate in a Polish population. Birth Defects Res A Clin Mol Teratol. 2012;94(11):943–50.View ArticlePubMedGoogle Scholar
  47. Menezes R, Marazita ML, Goldstein McHenry T, Cooper ME, Bardi K, Brandon C, Letra A, Martin RA, Vieira AR. AXIS inhibition protein 2, orofacial clefts and a family history of cancer. J Am Dent Assoc. 2009;140(1):80–4.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A, Al-Bahrani B. Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol. 2010;16(27):3432–6.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Kerrigan JJ, Mansell JP, Sengupta A, Brown N, Sandy JR. Palatogenesis and potential mechanisms for clefting. J R Coll Surg Edinb. 2000;45(6):351–8.PubMedGoogle Scholar

Copyright

© The Author(s). 2017